EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Clinical trials for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug for kids with rare blood diseases enters final testing phase
Disease control Recruiting nowThis study tests a medicine called benralizumab in children aged 6 to 17 with two rare diseases that cause too many eosinophils (a type of white blood cell). The goal is to see if the drug is safe and helps control the disease. About 14 children will take part, and the study is c…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
Pregnancy and vasculitis: new study seeks answers
Knowledge-focused Recruiting nowThis study tracks women with vasculitis who become pregnant to better understand how the disease affects pregnancy and what outcomes occur. Participants fill out online surveys during each trimester. No treatments or medications are tested—the goal is simply to gather information…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 06:50 UTC
-
Skin biopsies may unlock secrets of rare blood vessel disease
Knowledge-focused Recruiting nowThis study looks at skin samples from 50 people with different types of vasculitis, a condition where blood vessels become inflamed. Researchers want to understand how the disease affects the skin at a molecular level. Participants must have a skin rash or sore caused by active v…
Matched conditions: EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
Sponsor: Peter Merkel • Aim: Knowledge-focused
Last updated May 20, 2026 11:58 UTC